Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
273.88
+4.57 (1.70%)
At close: Dec 4, 2025
142.39%
Market Cap 4.09B
Revenue (ttm) 2.08B
Net Income (ttm) 443.72M
Shares Out 14.93M
EPS (ttm) 29.71
PE Ratio 9.22
Forward PE n/a
Dividend 16.74 (6.11%)
Ex-Dividend Date Nov 12, 2025
Volume 22,715
Average Volume 9,239
Open 269.31
Previous Close 269.31
Day's Range 270.35 - 283.00
52-Week Range 83.10 - 315.00
Beta 0.10
RSI 61.93
Earnings Date Dec 10, 2025

About EGX:CPCI

Kahira Pharmaceuticals & Chemical Industries Company engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt. The company is involved in the provision of chemicals, extracts, veterinary medicines, and pesticides; and packaging and distribution activities. It also exports its products to Iraq, Yemen, Sudan, Somalia, Jordan, Libya, Senegal, Zimbabwe, South Sudan, Mali, and Kenya. Kahira Pharmaceuticals & Chemical Industries Company was founded in 1962 and is headquartered in Cairo, Egypt. [Read more]

Industry Pharmaceutical Preparations
Founded 1962
Employees 1,760
Stock Exchange Egyptian Stock Exchange
Ticker Symbol CPCI
Full Company Profile

Financial Performance

In 2025, EGX:CPCI's revenue was 2.08 billion, an increase of 52.80% compared to the previous year's 1.36 billion. Earnings were 443.72 million, an increase of 80.29%.

Financial Statements

News

There is no news available yet.